A Response to the BMJ article “Gender Dysphoria in Young People is Rising – And So Is Professional Disagreement”

It is vitally important to continue the fight to save young children, particularly adolescent girls, from hormonal treatments that may permanently alter their bodies, and surgeries that may lead to profound regret.

This conclusion by the prestigious British Medical Journal (BMJ) shows incredible weakness of the arguments that medical organizations in the United States have used in favor of so-called “gender affirming care.” Flawed evidence is being presented in testimonies in front of legislative bodies and in promulgating recommendations for treatments that clearly, according to Norwegian experts, has the potential for doing more harm than good.

One of the key leaders of the evidence-based gender medicine movement, Dr. Gordon Guyatt, points out that the Endocrine Society guidelines vastly overstate the evidence for treating adolescents with new onset “gender dysphoria.”

Stanley Goldfarb, MD is the former associate dean of curriculum at the University of Pennsylvania Perelman School of Medicine and chairman of Do No Harm.